HK1222849A1 - 具有作爲 抑制劑的活性的取代的三唑並吡啶類 - Google Patents

具有作爲 抑制劑的活性的取代的三唑並吡啶類

Info

Publication number
HK1222849A1
HK1222849A1 HK16111004.3A HK16111004A HK1222849A1 HK 1222849 A1 HK1222849 A1 HK 1222849A1 HK 16111004 A HK16111004 A HK 16111004A HK 1222849 A1 HK1222849 A1 HK 1222849A1
Authority
HK
Hong Kong
Prior art keywords
mps
inhibitors
activity
substituted triazolopyridines
triazolopyridines
Prior art date
Application number
HK16111004.3A
Other languages
English (en)
Inventor
Volker K Schulze
Andreas Schall
Hans Briem
Antje Margret Wengner
Gerhard Siemeister
Detlef Stckigt
Philip Lienau
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of HK1222849A1 publication Critical patent/HK1222849A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/04Esters of boric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK16111004.3A 2013-06-07 2016-09-20 具有作爲 抑制劑的活性的取代的三唑並吡啶類 HK1222849A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13170978 2013-06-07
EP13186298 2013-09-27
PCT/EP2014/061416 WO2014195276A1 (en) 2013-06-07 2014-06-03 Substituted triazolopyridines having activity as mps-1 inhibitors

Publications (1)

Publication Number Publication Date
HK1222849A1 true HK1222849A1 (zh) 2017-07-14

Family

ID=50877309

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16111004.3A HK1222849A1 (zh) 2013-06-07 2016-09-20 具有作爲 抑制劑的活性的取代的三唑並吡啶類

Country Status (7)

Country Link
US (1) US20160264568A1 (zh)
EP (1) EP3004093A1 (zh)
JP (1) JP2016527193A (zh)
CN (1) CN105431435A (zh)
CA (1) CA2914521A1 (zh)
HK (1) HK1222849A1 (zh)
WO (1) WO2014195276A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS56034B1 (sr) * 2013-06-11 2017-09-29 Bayer Pharma AG Derivati prolekova supstituisanih triazolopiridina
CN107567503B (zh) 2015-04-17 2022-03-22 荷兰转化研究中心有限责任公司 用于ttk抑制剂化疗的预后生物标记
EP3956330A4 (en) 2019-04-18 2023-01-18 The Johns Hopkins University SUBSTITUTED 2-AMINO-PYRAZOLYL-[1,2,4]TRIAZOLO[1,5A]PYRIDINE DERIVATIVES AND THEIR USE

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57144234A (en) * 1981-03-03 1982-09-06 Sagami Chem Res Center 1-halophenyl-2-oxy-1-alkanone acetal
US4533734A (en) * 1983-11-10 1985-08-06 Eli Lilly And Company Inotropic agents
US7105544B2 (en) * 2001-07-05 2006-09-12 Synaptic Pharmaceutical Corporation Substituted alkyl amido piperidines
DK2054418T3 (da) * 2006-07-06 2012-02-27 Array Biopharma Inc Dihydrothieno-pyrimidiner som AKT-proteinkinase-inhibitorer
JO3598B1 (ar) * 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
TWI453207B (zh) * 2008-09-08 2014-09-21 Signal Pharm Llc 胺基三唑并吡啶,其組合物及使用其之治療方法
EP2343294A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Substituted triazolopyridines
US8754226B2 (en) * 2010-05-17 2014-06-17 Array Biopharma Inc. Piperidinyl-substituted lactams as GPR119 modulators
TW201204723A (en) * 2010-06-22 2012-02-01 Fovea Pharmaceuticals Heterocyclic compounds, their preparation and their therapeutic application
SI2699575T1 (sl) * 2011-04-21 2015-10-30 Bayer Intellectual Property Gmbh Triazolopiridini
CN104603136B (zh) * 2012-07-10 2017-06-27 拜耳医药股份有限公司 制备取代的三唑并吡啶的方法

Also Published As

Publication number Publication date
EP3004093A1 (en) 2016-04-13
CA2914521A1 (en) 2014-12-11
JP2016527193A (ja) 2016-09-08
WO2014195276A1 (en) 2014-12-11
CN105431435A (zh) 2016-03-23
US20160264568A1 (en) 2016-09-15

Similar Documents

Publication Publication Date Title
HK1222846A1 (zh) 取代的苄基吡唑
HK1221717A1 (zh) 取代的苄基吡唑
HK1223270A1 (zh) 長效螺異惡唑啉製劑
HK1216531A1 (zh) 新的抑制劑
HRP20171890T1 (hr) Supstituirani imidazopiridazini
HK1223362A1 (zh) 取代的吡唑並吡啶胺
EP3030071A4 (en) GROWING SYSTEM
HK1220972A1 (zh) 取代的噻唑並嘧啶
IL246271A0 (en) Converted piperidinyl-tetrahydroquinolines
GB201320432D0 (en) Novel formulation
IL246230A0 (en) Amines thf quinazoline as pde1 inhibitors
HK1222849A1 (zh) 具有作爲 抑制劑的活性的取代的三唑並吡啶類
GB201322948D0 (en) Improved formulation
HK1222652A1 (zh) 取代的三唑並吡啶類
HK1219728A1 (zh) 新型抗瘧疾藥劑
GB201317718D0 (en) Novel formulation
HK1220486A1 (zh) 啓動子組合物
GB201311560D0 (en) Concept twenty-nine
GB201317717D0 (en) Novel formulation
GB201307423D0 (en) Harrow
GB201303355D0 (en) Zippy Doodah